search icon

      Market Snapshot

      blog search icon

      Ardelyx Stock Price History and Quote Analysis: Insights for Investors

      Ardelyx, Inc.

      (NASDAQ:ARDX)

      $3.34

      -0.23 (-6.44%)

      At Close: 4:00 PM

      $3.25

      0.02 (0.62%)

      Pre Market: 5:45 AM

      Ardelyx Stock Price Graph

      • 1D
      • 5D
      • 1M
      • 3M
      • 6M
      • 1Y
      • YTD
      • All

      Ardelyx Stock Price Today

      Ardelyx, Inc. (ARDX) stock declined over -6.44% intraday to trade at $3.34 a share on NASDAQ. The stock opened with a loss of -0.84% at $3.54 and touched an intraday high of $3.55, falling -6.44% against the last close of $3.57. The Ardelyx, Inc. in stock market went to a low of $3.43 during the session.

      Ardelyx Stock Snapshot

      $3.57

      Prev. Close

      956.45 Million

      Market Cap

      $3.43

      Day Low

      $3.54

      Open

      207.02 Million

      Number of Shares

      $3.55

      Day High

      N/A

      P/E ratio

      -0.40

      EPS (TTM)

      0.61

      Cash Flow per Share

      9.86

      Free Float in %

      0.58

      Book Value

      4130312.00

      Volume

      Ardelyx Stock Price History Chart

      DateOpenHighLowCloseVolume
      2023-02-14$3.16$3.26$2.99$3.076401750.00
      2023-02-13$3.22$3.24$3.10$3.143407200.00
      2023-02-10$3.27$3.30$3.18$3.213190700.00
      2023-02-08$3.30$3.42$3.28$3.283765553.00
      2023-02-07$3.25$3.35$3.12$3.354949700.00
      2023-02-06$3.08$3.37$3.07$3.225922000.00
      2023-02-03$2.98$3.29$2.98$3.088110157.00
      2023-02-02$3.00$3.11$2.90$3.074677800.00
      2023-02-01$2.93$3.04$2.89$3.013853000.00
      2023-01-31$2.78$3.02$2.78$2.935271000.00

      Contact Details

      400 Fifth Avenue
      Waltham, MA 02451
      US

      Website:https://www.ardelyx.com

      Contact #:510 745 1700

      Company Information

      Employees133.00

      Beta1.19

      Sales or Revenue$63.06 Million

      5Y Sales Change4.40%

      Fiscal Year EndsDec. 2022

      SectorHealthcare

      IndustryBiotechnology

      About Company

      Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD. The company has agreements with Kyowa Kirin in Japan, Fosun Pharmaceutical Industrial Development Co. Ltd. in China, and Knight Therapeutics, Inc. in Canada for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

      Frequently Asked Questions

      icon

      What is the current Ardelyx, Inc. (ARDX) stock price?

      Ardelyx, Inc. (NASDAQ: ARDX) stock price is $3.34 in the last trading session. During the trading session, ARDX stock reached the peak price of $3.55 while $3.43 was the lowest point it dropped to. The percentage change in ARDX stock occurred in the recent session was -6.44% while the dollar amount for the price change in ARDX stock was -$0.23.

      icon

      ARDX's industry and sector of operation?

      The NASDAQ listed ARDX is part of Biotechnology industry that operates in the broader Healthcare sector. Ardelyx, Inc. , a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally.

      icon

      Who are the executives of ARDX?

      Mr. Robert Felsch
      Senior Vice President of Fin. & Chief Accounting Officer
      Dan Pavicich
      Senior Director of Market Devel.
      Ms. Kimia Keshtbod
      Mang. of Corporation Communications & Investor Relations
      Mr. Michael G. Raab
      Pres, Chief Executive Officer & Director

      icon

      How ARDX did perform over past 52-week?

      ARDX's closing price is 8.59% higher than its 52-week low of $0.49 where as its distance from 52-week high of $5.125 is -0.08%.

      icon

      How many employees does ARDX have?

      Number of ARDX employees currently stands at 133.00. ARDX operates from 400 Fifth Avenue</br>Waltham, MA 02451</br>US.

      icon

      Link for ARDX official website?

      Official Website of ARDX is: https://www.ardelyx.com

      icon

      How do I contact ARDX?

      ARDX could be contacted at phone #510 745 1700 and can also be accessed through its website. ARDX operates from 400 Fifth Avenue</br>Waltham, MA 02451</br>US.

      icon

      How many shares of ARDX are traded daily?

      ARDX stock volume for the day was 4130312.00 shares. The average number of ARDX shares traded daily for last 3 months was 7.14 Million.

      icon

      What is the market cap of ARDX currently?

      The market value of ARDX currently stands at $956.45 Million with its latest stock price at $3.34 and 207.02 Million of its shares outstanding.